BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1725944)

  • 1. Enzymatic investigation for delayed-type hypersensitivity reaction. Assay for thrombin and plasmin activities in tuberculin reaction sites.
    Imamura T; Kambara T
    Acta Pathol Jpn; 1991 Oct; 41(10):722-9. PubMed ID: 1725944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of thrombin and plasmin in development of delayed hypersensitivity reaction in guinea pig skin.
    Imamura T; Kambara T
    Inflammation; 1992 Apr; 16(2):169-77. PubMed ID: 1534318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-molecular-weight trypsinlike protease in the skin sites of delayed hypersensitivity in guinea pigs.
    Nakamura T; Yamamoto T; Ishimatsu T; Kambara T
    Am J Pathol; 1984 Feb; 114(2):250-63. PubMed ID: 6198919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory activity of a trypsin-like protease in the tuberculin reaction sites in guinea pig skin.
    Kambara T; Tanaka J; Nakamura T; Ishimatsu T
    Acta Pathol Jpn; 1986 Apr; 36(4):499-512. PubMed ID: 2425550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions.
    Colvin RB; Dvorak HF
    J Immunol; 1975 Jan; 114(1 Pt 2):377-87. PubMed ID: 1090656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S; DiLorenzo ME; Mann KG
    Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration.
    Colvin RB; Mosesson MW; Dvorak HF
    J Clin Invest; 1979 Jun; 63(6):1302-6. PubMed ID: 447844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemical mediation of delayed hypersensitivity skin reactions. IV. Activation of chemotactic factor precursor by a trypsin-like protease in guinea pig plasma.
    Kawaguchi T; Ueda K; Yamamoto T; Kambara T
    Am J Pathol; 1984 May; 115(2):307-15. PubMed ID: 6372498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte chemotaxis in inflammation. III. Demonstration of lymphocyte chemotactic activity in extract from PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.
    Shimokawa Y; Harita S; Higuchi Y; Hayashi H
    Br J Exp Pathol; 1982 Aug; 63(4):355-61. PubMed ID: 7150500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive study on the mechanism of inhibition of serine proteases by benzamidines based on quantitative structure-activity relationship studies.
    Gupta SP; Handa A; Shewade DG
    Arzneimittelforschung; 1987 Jan; 37(1):47-50. PubMed ID: 2952126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on proteases and alpha-macroglobulin activity in amphibian blood plasma.
    Kumar RS
    Indian J Exp Biol; 1997 Nov; 35(11):1198-202. PubMed ID: 9567750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New fluorogenic peptide substrates for plasmin.
    Kato H; Adachi N; Ohno Y; Iwanaga S; Takada K; Sakakibara S
    J Biochem; 1980 Jul; 88(1):183-90. PubMed ID: 6447693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased basal transepidermal water loss leads to elevation of some but not all stratum corneum serine proteases.
    Voegeli R; Rawlings AV; Doppler S; Schreier T
    Int J Cosmet Sci; 2008 Dec; 30(6):435-42. PubMed ID: 19099544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic properties and cytokine production of skin-infiltrating cells obtained from guinea pig delayed-type hypersensitivity reaction sites.
    Higashi N; Yoshizuka N; Kobayashi Y
    Cell Immunol; 1995 Aug; 164(1):28-35. PubMed ID: 7634350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.